We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » IVAX LAUNCHES GENERIC GLUCOVANCE, TRIGGERS AUTHORIZED PRODUCT
Generic drugmaker Ivax has shipped the first generic version of Bristol-Myers Squibb’s (BMS’) Type 2 diabetes drug Glucovance (glyburide/metformin HCl) tablets, a move that triggered the launch of BMS’ authorized generic product distributed by Par Pharmaceutical.